This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Nereus Pharmaceuticals, Inc.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Kazumi Akazawa: Innovator in Cell Division Inhibition
Introduction
Kazumi Akazawa is a prominent inventor based in Kurashiki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of cell division inhibitors. Her innovative work has the potential to impact various medical applications.
Latest Patents
Kazumi Akazawa holds a patent for a cell division inhibitor and a production method thereof. The patent describes a cell division inhibitor that comprises various dehydrodiketopiperazines, such as dehydrophenylahistin, or analogs thereof, as an active ingredient. Additionally, it includes a dehydrogenase and a method for producing the same inhibitor. This invention showcases her expertise in biochemistry and pharmacology.
Career Highlights
Kazumi Akazawa is currently associated with Nereus Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at the company focuses on innovative solutions in the pharmaceutical industry, particularly in the area of cell division and its implications for health.
Collaborations
Throughout her career, Kazumi has collaborated with notable colleagues, including Hiroshi Kanzaki and Kaneo Kanoh. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kazumi Akazawa is a trailblazer in the field of biotechnology, with her patent on cell division inhibitors highlighting her innovative spirit. Her contributions to Nereus Pharmaceuticals, Inc. and her collaborations with esteemed colleagues further solidify her position as a key figure in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
